| Attribute | Details |
|---|---|
| NCBI Gene ID | 100132911 |
| Synonyms | C20orf143, DPH3B, ZCSL1 |
| Protein Name | CSL-type zinc finger-containing protein 1 |
| Chromosomal Location | Chromosome 20 |
DPH3P1 has 1,296 functional associations across 8 biological categories, including molecular profiles, diseases, and chemical interactions . Key findings include:
Iron Binding: DPH3P1’s zinc finger domain enables iron coordination, critical for electron donation in diphthamide biosynthesis .
Immune Modulation: While not directly studied, DPH3P1’s homology to DPH3 suggests potential roles in immune-related pathways, as observed in hepatocellular carcinoma (HCC) studies involving DPH2/3 .
Chemical Interactions: DPH3P1 expression is modulated by toxins (e.g., aflatoxin B1), pharmaceuticals (e.g., cyclosporin A), and environmental agents (e.g., cadmium) .
Diagnostic Potential: While DPH3P1 itself is not directly linked to cancer, its homolog DPH3 is implicated in HCC prognosis. DPH2/3 overexpression correlates with tumor progression and immune evasion .
Therapeutic Targets: DPH3P1’s structural similarity to DPH3 raises questions about its role in toxin resistance or eEF2 modification .
Recombinant Protein Use: DPH3P1 is utilized in studies of diphthamide biosynthesis and toxin susceptibility .
Gene-Chemical Interactions: Notable responses to valproic acid (increased expression) and disulfiram (decreased expression) highlight regulatory complexity .
Diphthamide Deficiency Syndromes: Mutations in DPH1/2 cause developmental disorders linked to translation errors . While DPH3P1 is not yet associated with disease, its conservation suggests possible compensatory roles.
Drug Development: Targeting DPH3P1’s zinc finger domain could influence eEF2 activity, with implications for cancer or bacterial toxin therapies .
Functional Redundancy: Does DPH3P1 compensate for DPH3 loss in specific contexts?
Pathogenic Role: Is DPH3P1 dysregulation linked to cancer or immune disorders?
DPH3P1 (Diphthamide Biosynthesis 3 Pseudogene 1) is a human protein belonging to the DPH3 family. It consists of 78 amino acids and has a molecular weight of approximately 11.1 kDa. The protein is also known by several aliases including C20orf143, DPH3B, ZCSL1, and CSL-type zinc finger-containing protein 1 . As a member of the DPH3 family, it shares structural characteristics with other proteins involved in the diphthamide biosynthesis pathway, though as a pseudogene product, its functional role may differ from canonical DPH3 proteins. Understanding this classification is essential for researchers designing comparative studies or investigating evolutionary relationships between related proteins.
The full amino acid sequence of human DPH3P1 (residues 1-78) is:
MAVFHDEVEIEDFQYDEDSETTYFCPCPCGDNFSITKEELENGEGVAMCPCGSLIIKVIYDKDQFACGETVPVPSVNKE
When expressed as a recombinant protein with an N-terminal His-tag, the sequence typically includes additional amino acids for the tag and linker regions. This sequence information is critical for researchers designing targeted antibodies, planning site-directed mutagenesis experiments, or conducting structural analyses through techniques such as X-ray crystallography or NMR spectroscopy.
DPH3P1 contains CSL-type zinc finger domains, as indicated by one of its alternative names (CSL-type zinc finger-containing protein 1) . These domains typically coordinate zinc ions and are involved in DNA binding or protein-protein interactions. The protein contains cysteine-rich regions (as indicated by the sequence containing "CPCPCG" and "CPCGS" motifs) that likely form the zinc-coordinating structures . These structural features suggest potential involvement in transcriptional regulation or other nucleic acid-related functions. Researchers investigating protein-protein or protein-DNA interactions should focus experimental designs on these domains, potentially using truncation mutants to isolate specific functional regions.
Escherichia coli is the most commonly documented expression system for recombinant human DPH3P1 production . This bacterial expression system offers several advantages for protein research including:
High yield of protein expression
Cost-effectiveness for large-scale production
Well-established protocols for induction and purification
Compatibility with N-terminal His-tag constructs for affinity purification
When designing expression experiments, researchers should consider optimizing codons for E. coli usage, controlling induction conditions (IPTG concentration, temperature, and duration), and selecting appropriate E. coli strains that enhance disulfide bond formation, which may be important for the zinc finger domains in DPH3P1.
Based on the available recombinant protein products, a multi-step purification strategy is recommended to achieve >90% purity for DPH3P1 :
Initial IMAC Purification: Utilizing the N-terminal His-tag for immobilized metal affinity chromatography (typically Ni-NTA)
Secondary Chromatography: Size exclusion or ion-exchange chromatography to remove contaminants and aggregates
Quality Control: SDS-PAGE analysis to confirm purity, with expected migration at approximately 11.1 kDa
The purification buffer system typically consists of 20mM Tris-HCl (pH 8.0) containing 10% glycerol . The addition of glycerol helps stabilize the protein structure during storage. For researchers requiring ultra-high purity for crystallography or other sensitive applications, additional purification steps such as hydrophobic interaction chromatography may be considered.
When investigating DPH3P1's role in cellular pathways, consider implementing a systematic experimental design approach:
Hypothesis Formulation: Based on the protein's zinc finger domains, hypothesize potential roles in transcriptional regulation or nucleic acid binding
Variable Identification: Define independent variables (e.g., DPH3P1 expression levels) and dependent variables (e.g., expression of potential target genes)
Control Selection: Include appropriate controls such as cells with endogenous DPH3P1 levels, knockdown/knockout cells, and cells expressing a mutated form of DPH3P1
Experimental Treatments: Design treatments that manipulate DPH3P1 expression or function (overexpression, knockdown using CRISPR/Cas9, inhibition of interaction partners)
Measurement Methods: Plan specific assays to measure outcomes, including protein-protein interaction studies, transcriptional reporter assays, or phenotypic analyses
For CRISPR-Cas9 targeting of DPH3P1, researchers should consider the following approach:
Guide RNA Selection: Multiple gRNAs targeting different exons of DPH3P1 have been designed by the laboratory of Feng Zhang at the Broad Institute to minimize off-target effects. Order at least two different gRNA constructs to increase the likelihood of successful gene editing .
Validation Strategy: Confirm successful editing through:
PCR amplification and sequencing of the targeted region
Western blot analysis to verify protein depletion
RT-qPCR to assess transcript levels
Experimental Controls: Include wild-type cells and cells transfected with non-targeting gRNAs as essential controls
Phenotypic Assessment: Systematically evaluate cellular phenotypes following successful DPH3P1 knockout, focusing on processes potentially related to the protein's predicted function
This methodological approach ensures rigorous validation of CRISPR-mediated gene editing and reliable interpretation of subsequent functional studies .
For accurate quantification of DPH3P1 expression in tissue samples, researchers should implement a multi-method approach:
Immunohistochemistry (IHC) with H-Score Assessment: Similar to the methodology used for other proteins like SULF1, DDR1, PKCι, and SPARC in tissue studies :
Use specific anti-DPH3P1 antibodies validated for IHC
Implement a standardized H-scoring system (0-3 intensity scale)
Have multiple researchers score samples independently to ensure reliability
Calculate mean H-scores and perform correlation analysis between scorers
Quantitative Proteomics:
Use targeted mass spectrometry approaches such as selected reaction monitoring (SRM)
Include isotopically labeled standard peptides for absolute quantification
Analyze data using appropriate statistical methods to determine significance of expression differences
Western Blot Quantification:
Use housekeeping proteins as loading controls
Implement densitometric analysis with appropriate normalization
Include calibration curves with recombinant DPH3P1 for absolute quantification
This comprehensive approach provides both visual assessment of expression patterns and objective quantitative measurements, essential for robust differential expression analysis.
Distinguishing DPH3P1 from other DPH3 family proteins presents several methodological challenges that researchers must address:
Sequence Homology Considerations:
DPH3P1 (also known as DPH3B) shows significant sequence similarity to canonical DPH3 (DPH3A)
Design experiments that account for this homology through highly specific detection methods
Antibody Specificity:
Validate antibodies using recombinant proteins and knockout cell lines
Consider epitope mapping to identify unique regions for generating DPH3P1-specific antibodies
Implement antibody pre-absorption with recombinant related proteins to improve specificity
Transcript Detection:
Design PCR primers that target unique regions of DPH3P1 mRNA
Validate primers using synthetic templates containing sequences from different DPH3 family members
Consider digital PCR for absolute quantification with higher specificity
Functional Discrimination:
Design assays that can distinguish potential functional differences between DPH3P1 and other family members
Consider complementation studies in knockout systems to determine functional redundancy
These methodological approaches help ensure experimental results specifically reflect DPH3P1 biology rather than effects from other DPH3 family proteins.
Based on recommended storage protocols for recombinant DPH3P1, researchers should implement the following conditions to maintain protein stability and activity:
Short-term Storage (up to 1 week):
Long-term Storage:
Stability Assessment:
Periodically verify protein integrity via SDS-PAGE
Test functional activity after extended storage before using in critical experiments
Monitor for signs of aggregation or precipitation
These storage protocols help maintain DPH3P1 in its native conformation and preserve its biochemical properties for reliable experimental outcomes.
To minimize damage from freeze-thaw cycles, which can significantly impact protein structure and function:
Aliquoting Strategy:
Divide protein preparations into single-use aliquots immediately after purification
Use volumes appropriate for typical experiments to avoid repeated freezing
Consider using smaller aliquots for valuable protein preparations
Thawing Methodology:
Thaw aliquots rapidly by gentle agitation in a water bath at room temperature
Avoid elevated temperatures that may denature the protein
Once thawed, keep on ice and use within the same day
Quality Control:
After thawing, centrifuge briefly to remove any aggregates
Check protein concentration after thawing to account for potential losses
Consider assessing zinc retention in the zinc finger domains if critical for function
Implementing these practical approaches significantly extends the useful life of DPH3P1 protein preparations and ensures experimental reproducibility .
Given DPH3P1's structural features including zinc finger domains, researchers should consider these specialized biochemical assays:
DNA/RNA Binding Assays:
Electrophoretic Mobility Shift Assays (EMSA) to detect nucleic acid binding
Fluorescence Anisotropy to determine binding kinetics and affinity
Chromatin Immunoprecipitation (ChIP) to identify genomic binding sites in vivo
Protein Interaction Studies:
Co-immunoprecipitation with potential interacting partners
Yeast two-hybrid screening to identify novel interactions
Proximity ligation assays for visualizing interactions in cellular contexts
Zinc Binding Characterization:
Atomic absorption spectroscopy to quantify zinc content
Circular dichroism to assess structural changes upon zinc binding/removal
Thermal shift assays to evaluate stabilization by zinc
Enzymatic Activity Assessment:
Given its relationship to DPH3 family, test for potential roles in diphthamide biosynthesis
Evaluate post-translational modification capabilities or targets
These methodological approaches provide complementary information about DPH3P1's biochemical properties and potential cellular functions, guiding more targeted functional studies.
Differentiating direct from indirect effects requires a methodical experimental approach:
Temporal Analysis:
Implement time-course studies after DPH3P1 manipulation
Primary (direct) effects typically occur more rapidly than secondary effects
Use inducible expression systems for precise temporal control
Rescue Experiments:
Re-express wild-type DPH3P1 in knockout systems to confirm specificity
Use domain mutants to identify regions responsible for specific effects
Implement partial rescues with related proteins to determine functional specificity
Proximity-Based Methods:
Use BioID or APEX2 proximity labeling to identify proteins physically close to DPH3P1
Crosslinking approaches to capture direct binding partners
High-resolution microscopy to visualize co-localization at subcellular level
In Vitro Reconstitution:
Recapitulate observed effects in cell-free systems using purified components
Systematically add potential intermediary factors to test for indirect effects
This systematic approach helps establish causal relationships and distinguish primary effects from downstream consequences, essential for accurate functional characterization.
Based on current knowledge of DPH3P1 and related proteins, several high-priority research directions emerge:
Functional Genomics Approaches:
Comprehensive CRISPR screens to identify genetic interactions with DPH3P1
Transcriptomic profiling following DPH3P1 manipulation to identify regulated pathways
Proteomic analysis to map the DPH3P1 interactome
Structural Biology:
Determination of DPH3P1's three-dimensional structure through X-ray crystallography or cryo-EM
Comparative structural analysis with canonical DPH3 proteins
Structure-guided design of domain-specific inhibitors or activators
Disease Relevance:
Evolution and Conservation:
Comparative analysis across species to understand evolutionary constraints
Investigation of potential pseudogene-specific functions that may have evolved
These research directions will contribute to a more comprehensive understanding of DPH3P1's biological significance and potential applications in biomedical research.
When confronted with contradictory data regarding DPH3P1 function or expression:
Methodological Reconciliation:
Carefully examine differences in experimental approaches
Consider cell type-specific or context-dependent effects
Evaluate reagent specificity, particularly antibodies that may cross-react with related proteins
Systematic Verification:
Reproduce key experiments using multiple methodologies
Implement orthogonal approaches to verify critical findings
Collaborate with labs reporting contradictory results to standardize protocols
Biological Complexity Considerations:
Explore potential post-translational modifications that may explain functional differences
Consider alternative splicing or processing that could generate different protein isoforms
Evaluate impact of experimental conditions (stress, cell density, medium composition)
Transparent Reporting:
Thoroughly document all experimental conditions
Report both confirming and contradicting observations
Discuss limitations and potential confounding factors
This methodical approach to contradictory data transforms challenges into opportunities for deeper understanding of DPH3P1 biology and more robust experimental design.
Diphthamide Biosynthesis 3 Pseudogene 1 (DPH3P1) is a pseudogene associated with the diphthamide biosynthesis pathway. Pseudogenes are segments of DNA that resemble functional genes but typically lack the ability to encode proteins due to mutations or deletions. Despite this, pseudogenes can play roles in gene regulation and evolution.
While DPH3P1 itself is a pseudogene and does not produce a functional protein, its parent gene, DPH3, plays a significant role in the diphthamide biosynthesis pathway. Diphthamide is essential for the proper function of EF-2, and its modification is critical for cellular protein synthesis. The diphthamide modification is also the target of diphtheria toxin, which inactivates EF-2, leading to the inhibition of protein synthesis and cell death.
Human recombinant DPH3P1 is used in research to study the regulatory mechanisms of pseudogenes and their potential roles in gene expression and cellular processes. Understanding the function and regulation of pseudogenes like DPH3P1 can provide insights into genetic evolution and the complexity of gene regulation networks.